The treatment landscape of Inflammatory Bowel Disease (IBD) has undergone a significant transformation over the past two ...

Switching back from infliximab biosimilar SB2 to reference infliximab (Remicade) did not affect clinical disease activity or ...

TNF-α is a potent inductor of the inflammatory response, a key cytokine in the development of the innate immune response. Soluble TNF-α acts on many hematopoietic and nonhematopoietic cell types ...

Schematic of TNF inhibitors and their mode of action. Receptor (i.e. etanercept, lenercept) and antibody based (i.e. infliximab, adalimumab, golimumab) anti-TNF biologics inhibit both solTNF and ...

instead of tumour necrosis factor like Remicade. Company expects reported sales growth of 2-3% in 2016. In Q3, total sales were $17.8 billion, an increase of 4.2% compared with the same period ...

PayPal Holdings, Inc. operates a technology platform that enables digital payments for merchants and consumers worldwide. It operates a two-sided network at scale that connects merchants and ...

Alibaba Group Holding Limited, through its subsidiaries, provides technology infrastructure and marketing reach to help merchants, brands, retailers, and other businesses to engage with their ...

Jan. 28, 2025 — A new study shows that asymptomatic brain metastasis is more common in stage 4 breast cancer patients than previously believed. The study suggests ... Route of Entry for Semliki ...

We investigated whether patients with inflammatory bowel disease treated with infliximab have attenuated serological ... Salisbury District Hospital: Alpha Anthony, Emily Newitt. Sandwell and West ...

Some patients were candidates for inclusion in the large randomised controlled trial on the efficacy of infliximab in AS performed in Germany. 5 All had been conventionally treated with non-steroidal ...